Objective Preterm birth rates are rising but clinical prediction models are limited. Accurate prediction enables interventions to be targeted to at risk women. Single threshold (50ng/ml) fetal fibronectin (fFN) and cervical length (CL) Conclusions sPTB in high-risk asymptomatic women can be accurately predicted using a model combining qfFN and CL which supersedes the single threshold fFN test, demographic information and obstetric history. This algorithm has been incorporated into an app for widespread use.
Introduction
Every year 15 million babies are born prematurely worldwide, (before 37 weeks' completed gestation) 1 Neonatal intensive care and ongoing medical and educational support is expensive -$26 billion annually in the US 3 and, despite advances in prenatal care, the rate of preterm birth has not declined.
2
Prediction of preterm birth in women at risk should allow targeted intervention. Both cerclage and progesterone have shown promise in reducing spontaneous preterm birth (sPTB) in asymptomatic women, particularly in those with a short cervix. 4, 5, 6, 7 More recently fetal fibronectin (fFN) and cervical length (CL) assessment have superseded previous risk assessment, not only in women symptomatic of preterm birth, but in asymptomatic women where prophylactic preventative therapies can be attempted. 8, 9 Cervicovaginal fluid (CVF) quantitative fFN (qfFN) concentration measurement adds value over the qualitative test in both symptomatic and high-risk asymptomatic women, 10, 11 ,12 and is now available in a simple point of care test in 10 minutes (Hologic 10Q).
We prospectively evaluated clinical risk factors, qfFN and CL measurements taken from high-risk women attending a preterm surveillance clinic to create an optimal risk algorithm.
This was then validated on a separate data set of high-risk women.
Methods

This was a prospective blinded secondary analysis of a population of women enrolled in the ongoing EQUIPP (Evaluation of Fetal Fibronectin with a Quantitative Instrument for the Prediction of Preterm Birth) involving 1249 consecutive asymptomatic women deemed to be
This article is protected by copyright. All rights reserved at high risk of spontaneous preterm birth, defined as one or more of: previous sPTB or previous preterm rupture of membranes (PPROM) <37 weeks', previous late miscarriage (16-23+6), previous cervical surgery or cervical length measuring <25 mm in the current pregnancy.
Asymptomatic women attending high-risk preterm surveillance clinics were offered longitudinal fetal fibronectin testing using a novel quantitative rapid fFN analyser (Hologic) every 2-4 weeks in addition to routine transvaginal ultrasound length measurement. All highrisk women between 22 +0 -30 +0 weeks' gestation asymptomatic of threatened sPTB were considered. From this group, exclusions were sequentially performed to provide the most uniform population for comparative analysis. Women with a blood stained swab or sexual intercourse within the last 24 hours were excluded from the study due to known interference with fFN measurement. 13 Women with multiple pregnancy, those without CL measurement, or those with insufficient or absent qfFN sample, incomplete outcome data or offspring from the current pregnancy with a congenital abnormality were also excluded. This article is protected by copyright. All rights reserved both fFN analysers ran the two tests concurrently. Clinicians were made aware of the Categoric TL IQ result (positive/negative), but 10Q results remained double-blinded to both patient and clinician until after delivery (a random result code was generated by the analyser).
Participants' demographic characteristics, risk factors and obstetric and gynaecological history were entered into a secure online database (www.medscinet.net/PTBstudies). Three CL measurements were taken at each visit using transvaginal ultrasonography and the minimum cervical length was used.
Women were managed in the clinic as per unit protocols. History indicated cerclage was inserted when a woman had experienced 3 or more late miscarriages or previous sPTB <34 weeks and ultrasound indicated cerclage was inserted if a short cervix was detected on ultrasound (n=140; training set = 79; validation set = 61). Progesterone (or placebo) was Any model performs optimally on the data set used to generate the model. In order to provide a true assessment of the usefulness of the model it should be validated on another data set from a similar population. To this end the study population was split to form a training set, consisting of 624 women with 1245 visits, which was used to develop the model and a validation set, which included 625 women with 1243 visits. A predictive model was run using the validation set to assess the performance of the algorithm.
Statistical methods
Data sets
Statistical analysis was performed with Stata software (version 11.2; StataCorp LP, College
Station, Texas). The data was randomly split 1:1 into training and validations sets, each
This article is protected by copyright. All rights reserved woman providing qfFN and CL measurement on at least one occasion. All test results from all women were included in the analysis.
Model generation
Survival analysis with time-updated covariates was used to identify the principal predictors of premature delivery with premature onset of labour or PPROM. For each set of results, women were considered at risk of an event only from the time of the visit to the earliest of; their next test, delivery or 37 weeks' gestation. Deliveries after 37 weeks' gestation or preceded by induction of labour or elective caesarean section were regarded as censored. Fetal fibronectin, CL, gestation of test and previous preterm delivery/ PPROM were considered as possible predictors. We performed an initial analysis where other predictive variables including BMI, smoking, ethnicity, previous cervical surgery and previous late miscarriage, were excluded as not significant.
Six parametric survival models were compared for each combination of predictors:
exponential, Gompertz, loglogistic, Weibull, lognormal, and gamma.
The best survival function was determined by having the lowest values of the Akaike and Bayesian Information Criteria (AIC and BIC). 14, 15 A lognormal survival function with terms for qfFN, CL and previous sPTB/ PPROM was selected. The continuous measures qfFN and CL were then investigated for non-linearity using fractional polynomials 16 This article is protected by copyright. All rights reserved
Model validation
The probabilities of delivery before 5 clinically important gestations (30, 34, 37 weeks of pregnancy and within 2 and 4 weeks of testing) were compared to actual event rates in both training and validation sets: ROC curves were drawn, and areas under the curve (AUROC) calculated.
The sensitivity and specificity of the algorithm was investigated using a probability above 10% as indicating a positive test. This value was chosen as being practically useful for separating low-risk women (probability around 5%) from high-risk women (probability around 20%) for purposes of clinical management.
Results
After exclusions, illustrated in figure 1 , the final high-risk population studied consisted of 1249 women and, including longitudinal sampling, 2488 fFN measurements were recorded.
This final group was split into a training set, consisting of 624 women with 1245 visits, and a validation set of 625 women and 1243 visits. The mean gestational age of visit was 23.35 in the training set and 23.39 in the validation set.
The rate of sPTB was 16%, 8%, 4%, 1% and 2% for delivery at <37, <34 and <30 weeks' and within 2 and 4 weeks of test respectively in the training set and 15%, 8%, 4%, 1% and 2% respectively in the validation set.
The proportion of women in each fFN concentration category and CL values were similar between training and validation sets ( 
Model generation (using the training set only).
Of the predictors considered, qfFN, CL and previous sPTB/ PPROM were significant in the stepwise model at p <0.01. The best parametric survival model (determined by AIC and BIC) was a lognormal survival function with terms for qfFN, CL and previous sPTB or PPROM. The best fractional polynomial model was linear in CL and the square root of fFN concentration. Overall, predictive statistics including sensitivity, specificity, LR+, LR-are similar for training and validation sets across all 5 gestations.
Model validation
Furthermore the prediction of sPTB using the prediction model is good. The NPV is >90 for all 5 gestations which means that <10 % of women with a negative test will deliver preterm.
This is clearly in line with the definition of a negative test (calculated probability < 10%), and confirms that the calculated probabilities are behaving as intended. The LR+ and LR-are all much greater than 1 or less than 1 respectively which indicates that positive test results are strongly associated with sPTB and negative tests results with its absence. 17 respectively are reported. 18 It has consistently been shown that additional information is available when fFN results are quantified. 10, 11, 12, 19 In addition combined qfFN testing and CL measurement has been shown to lead to improved prediction of sPTB. 20 This could explain improved ROC areas for the new predictive model which incorporates information obtained from the measurement of qfFN and CL compared to qfFN testing alone. Combining CL and qfFN is likely to be best, and this is consistent with our data and probably supersedes any other variables.
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The superiority of combined qfFN and CL measurement as predictors of preterm birth was further implied by stepwise regression where all proposed variables, save qfFN, CL and previous sPTB/ PPROM were rejected as non-significant. However, the list of variables was not exhaustive and there may be others which affect prediction of sPTB. For example, there is evidence to suggest that having a cervical cerclage in situ may affect fFN result. Duhig et al showed that for delivery at <30 weeks the specificity of FFN testing was significantly lower in asymptomatic high risk women with cervical cerclage compared to those without, (77 vs 90%; p< 0.00001), and this was attributed to increased false positive results. 21 Further work is required to establish whether cervical cerclage and other variables could be included in the model to improve its performance. Currently, with 17% of the women in this cohort receiving cerclage, the model is good and can be used.
The fact that the data was derived from a rigorously, prospectively collected dataset (used for the EQUIPP study), the largest of its kind, is a strength of this study, which is the first to develop a model for the creation of an algorithm to predict sPTB in asymptomatic high risk women including quantifiable fFN. Furthermore, the parametric method used to generate the model, combined with appropriate censoring, makes full use of the available data, without introducing biases. As a result the sPTB rate in this study, which is similar to that reported in recent studies 9,11,12 analysing qfFN in asymptomatic women, is likely to be a good representation of sPTB in asymptomatic high risk women in the general population. This further suggests that the model generated in this study will be relevant beyond this study population and an accurate predictive tool.
A potential limitation of the study is that predictive statistics were based on results derived from women managed in Preterm Surveillance Clinics as per protocols, which included interventions such as ultrasound indicated cerclage (17%) and progesterone (5%) as part of OPPTIMUM, an on-going randomised controlled trial. The predictive model remains good
This article is protected by copyright. All rights reserved even under these circumstances, i.e. women both with and without intervention can rely on it to predict outcome. As interventions are not only to prolong gestation, e.g. steroids and magnesium sulphate to improve neonatal morbidity, the information remains potentially valuable. Further work needs to ascertain if interventions improve outcome when targeted to women identified with the algorithm, but some interventions may be withheld in women with poor history, determined as low risk by the algorithm. Determining risk without these interventions would be unethical, and the algorithm remains pragmatic and valuable for this reason.
Further work has been done to update the model for use in symptomatic as well as asymptomatic women. Ultimately, the algorithm will be made widely available to clinicians through an application accessed from a smart phone or via the internet. It performs significantly better than any previous predictive tool. This article is protected by copyright. All rights reserved (15) 90 (14) 185 (15) This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved 
